Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133629) titled 'Biomimetic perfusable vascular chip reveals the regulatory mechanism of macrophage-mediated immune inflammation in atherosclerosis' on Sept. 29.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Dongguan People's Hospital
Condition:
Atherosclerosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-29
Target Sample Size: Sampling Group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345832
Published by HT Digital Content Services with permission from Health Daily Digest....